Comparison of the Ultrasound-guided Paravertebral Nerve Block With Liposomal Bupivacaine Versus Ropivacaine for Post-Surgical Pain After Video-Assisted Thoracoscopic Surgery

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

December 21, 2025

Study Completion Date

December 21, 2025

Conditions
Analgesia
Interventions
DRUG

Liposomal bupivacaine

133mg LB 20mL thoracic paravertebral nerve block

DRUG

Ropivacaine

0.5% ropivacaine 20mL thoracic paravertebral nerve block

Trial Locations (1)

430030

Tongji Hospital, Wuhan

All Listed Sponsors
lead

Feng Gao

OTHER